Non-small cell lung cancer

• ETOP 18-21 AMAZE-lung: A clinical study exploring the effect of amivantamab and lazertinib plus bevacizumab treatment, in people diagnosed w … Recruitment ended
  2024-512288-29-00 4 2023-04-11 "Patients with EGFR-mutant (L858R or del19 only) advanced non"
• A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Un … Recruitment ended
  2023-505211-21-00 4 2023-03-10 "Previously untreated locally advanced or metastatic non-smal"
• Phase I, open-label study to evaluate the safety and immune activity of PeptiCRAd-1, an oncolytic virus coated with tumor-specific peptides … Recruitment ended
  2024-517580-23-00 1 2023-03-07 "Sarcoma"
• An Open-Label Phase 1/2 Trial to Evaluate the Safety, Tolerability, and Efficacy of MORAb 202 in Subjects with Selected Tumor Types. Recruitment ended
  2023-506868-14-00 9 2023-02-28 "Solid tumors in 4 tumor types: platinum resistant ovarian ca"
• An open-label, single-arm, Phase II, multinational, multicentre study to assess the efficacy and safety of 5 years of osimertinib in partici … Recruitment ended
  2023-508740-21-00 4 2023-02-15 "Non-Small Cell Lung Cancer"
• An Interventional and Translational Study investigating Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With M … Recruitment ended
  2024-510837-16-00 4 2022-12-13 "locally-advanced and unresectable or metastatic NSCLC with K"
• Phase 1b Study of Dato-DXd in Combination with Immunotherapy with or without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cance … Recruitment ended
  2023-505992-54-00 3 2022-10-21 "Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)"
• Study of DS-1062a with or without Pembrolizumab in Advanced or Metastatic Non-small Cell Lung Cancer without Actionable Genomic Alterations Recruitment ended
  2023-507933-12-00 5 2022-08-18 "Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)"
• A Clinical Study of Lazertinib with Subcutaneous Amivantamab Compared with Intravenous Amivantamab in Patients with EGFR-mutated Advanced or … Recruitment ended
  2024-512045-16-00 5 2022-08-18 "EGFR-mutated Advanced or Metastatic Non-small Cell Lung Canc"
• Lorlatinib Continuation Study Recruitment ended
  2023-508952-21-00 6 2022-08-02 "Lung cancer"
• A phase 1/1b/2 study of AMG 193 alone and in combination with docetaxel in subjects with advanced MTAP-null solid tumors. Recruitment ended
  2023-504363-17-00 7 2022-05-13 "Advanced MTAP-null solid tumors"
• A Phase 2 Study of Sacituzumab Govitecan Combinations in First-line Treatment of Patients with Advanced or Metastatic Non−Small-Cell Lung Ca … Recruitment ended
  2024-513225-23-00 4 2022-04-07
• Master Protocol of Sotorasib (AMG 510) in Subjects with Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreaK 101) Recruitment ended
  2023-506794-35-00 3 2022-04-01 "Advanced Solid Tumors Kirsten Rat Sarcoma (KRAS) pG12C Mutat"
• A study of Sacituzumab Govitecan Versus Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC). Recruitment ended
  2024-512148-50-00 5 2022-03-03
• Radiation during Osimertinib Treatment: a Safety and Efficacy Cohort Study (ROSE) Recruitment ended
  2022-503028-29-01 4 2021-12-14 "Patients with stage IV EGFR-mutation positive NSCLC target p"
• Study of Nivolumab and Ipilimumab plus chemotherapy as a treatment for patients with stage IV lung cancer with brain metastases. Recruitment ended
  2024-513866-20-00 4 2021-11-18 "Non-small cell lung cancer with brain metastasis"
• A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lun … Recruitment ended
  2023-507494-18-00 5 2021-09-24 "Non-small cell lung cancer with ROS proto-oncogene 1, recept"
• Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung … Recruitment ended
  2024-513770-22-00 4 2021-09-22 "Malignant Solid Tumors - Non Small Cell Lung Cancer"
• DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer Recruitment ended
  2023-509865-19-00 5 2021-04-30 "Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)"
• Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants with Advanced NSCLC … Recruitment ended
  2023-507475-21-00 10 2021-01-18 "Lung Cancer, Non-Small Cell"
• Phase 3 Study of MRTX849 vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation Recruitment ended
  2023-507263-19-00 5 2020-12-23 "Advanced Non-Small Cell Lung Cancer"
• A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients with Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung … Recruitment ended
  2024-511185-37-00 6 2020-11-03 "Completely resected stage I or IIA non-squamous non-small ce"
• A Randomized, Open-label Phase 3 Study of Combination Amivantamab and CarboplatinPemetrexed Therapy, Compared with Carboplatin-Pemetrexed, i … Recruitment ended
  2023-506033-29-00 5 2020-10-09 "EGFR Exon 20ins Mutated Locally Advanced or Metastatic Non-S"
• A Clinical Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib Versus Lazertinib as First-Line Treatment in Patients … Recruitment ended
  2023-506576-27-00 5 2020-09-30 "EGFR-mutated locally advanced or metastatic Non Small Cell L"

Showing 121–144 of 234 trials